… ), kidney disease and heart failure. Mission Therapeutics labMitochondria are energy-producing … mitochondrial quality. Mission Therapeutics is currently developing two … Lundemose, executive director, Mission TherapeuticsDr Anker Lundemose, executive director …

… down its cell and gene therapy (CGT) division after an … targeting Parkinson’s disease, chronic heart failure, and Type 1 diabetes. Japanese … Takeda also abandoned its cell therapy research, in a surprise U … for off-the-shelf cell therapies that was valued at …

… investigational gene therapy in participants with congestive heart failure (CHF).1 … pipeline that includes investigational therapeutics for congestive heart failure, limb-girdle muscular … R. Cardiotropic AAV gene therapy for heart failure: a phase 1 trial. …

… cardiac outcomes. Chronic heart failure scenarios further compound mitochondrial … apoptotic machinery, progressing therapeutic options for refractory myelodysplastic … repertoire of mitochondria-targeted therapeutics, including antioxidants, apoptosis …

… Heart Failure Management Diuretics serve as essential but symptomatic therapy in heart failure … other guideline-directed medical therapies that provide more comprehensive … importance of optimizing other heart failure therapies to minimize diuretic dependence …

… transthyretin stabilizers and gene-silencing therapies have been developed recently, … new drugs like gene-silencing therapies have emerged, showing effectiveness in … heart, treatment focuses on managing heart failure and arrhythmias,” Professor Jeon said …

… ’s criteria for Comprehensive Heart Failure Center Certification, cementing the … hospitals provide guideline-directed medical therapies. “This milestone reflects … rigorous standards for Comprehensive Heart Failure Center Certification, Instituto Nacional …

… established benefits of cholesterol-lowering therapies,” said Peter Libby, MD … driver of atherosclerosis, arrhythmias, heart failure and related cardiometabolic disorders.   The … company developing innovative oral therapies for patients with autoimmune, …